ENPP2 and breast carcinoma: ATX, LPAR1 and LPAR2 are overexpressed in different tumor types, including ovarian cancer, osteocarcinoma, metastatic melanoma, neuroblastoma, breast cancer, pancreatic cancer, prostate cancer, and hepatocellular carcinoma [43,60].